CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,000 | -60.0% | 21,247 | 0.0% | 0.00% | – |
| Q3 2018 | $10,000 | -9.1% | 21,247 | -0.2% | 0.00% | – |
| Q2 2018 | $11,000 | -80.4% | 21,281 | -11.2% | 0.00% | – |
| Q1 2018 | $56,000 | -17.6% | 23,970 | 0.0% | 0.00% | – |
| Q4 2017 | $68,000 | +11.5% | 23,970 | +13.1% | 0.00% | – |
| Q3 2017 | $61,000 | +15.1% | 21,199 | -0.6% | 0.00% | – |
| Q2 2017 | $53,000 | +23.3% | 21,324 | +81.1% | 0.00% | – |
| Q1 2017 | $43,000 | +10.3% | 11,777 | +7.3% | 0.00% | – |
| Q4 2016 | $39,000 | -15.2% | 10,977 | -4.4% | 0.00% | – |
| Q3 2016 | $46,000 | -84.3% | 11,477 | -1.3% | 0.00% | -100.0% |
| Q2 2015 | $293,000 | -22.5% | 11,627 | -14.4% | 0.00% | -50.0% |
| Q1 2015 | $378,000 | – | 13,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
| TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
| Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
| Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
| Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
| LMR Partners LLP | 408,846 | $206,000 | 0.01% |